These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2499742)

  • 1. The anti-conflict effect of cyproheptadine is not mediated by its 5-hydroxytryptamine antagonistic property.
    Ketelaars CE; Bruinvels J
    Life Sci; 1989; 44(23):1743-9. PubMed ID: 2499742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of the benzodiazepine midazolam and three serotonin antagonists on a consummatory conflict paradigm.
    Becker HC
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1057-64. PubMed ID: 3012590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased food intake in satiated rats induced by the 5-HT antagonists methysergide, metergoline and ritanserin.
    Fletcher PJ
    Psychopharmacology (Berl); 1988; 96(2):237-42. PubMed ID: 3148151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of serotonergic drugs on negative contrast in consummatory behavior.
    Flaherty CF; Grigson PS; Demetrikopoulos MK; Weaver MS; Krauss KL; Rowan GA
    Pharmacol Biochem Behav; 1990 Aug; 36(4):799-806. PubMed ID: 2145592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent effects of cyproheptadine and R 50 656, a 5-HT2 antagonist, on the cardiovascular response to 5-hydroxytryptamine in rats.
    Krstić MK; Katusić ZS
    Eur J Pharmacol; 1982 Nov; 85(2):225-7. PubMed ID: 6129985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of 5HT2 receptor blockade on the startle reflex and its prepulse inhibition in mice and rats of various strains].
    Popova NK; Barykina NN; Alekhina TA; Naumenko KS; Kulikov AV
    Ross Fiziol Zh Im I M Sechenova; 1999 Jun; 85(6):857-64. PubMed ID: 10512006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism.
    Cohen ML; Bloomquist WL; Snoddy HD; Fuller RW
    Life Sci; 1989; 45(13):1185-9. PubMed ID: 2507847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the 5HT2 antagonist ritanserin on food intake and on 5HT-induced anorexia in the rat.
    Massi M; Marini S
    Pharmacol Biochem Behav; 1987 Feb; 26(2):333-40. PubMed ID: 3106990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tremorogenesis by physostigmine is unrelated to acetylcholinesterase inhibition: evidence for serotoninergic involvement.
    Mohanakumar KP; Mitra N; Ganguly DK
    Neurosci Lett; 1990 Nov; 120(1):91-3. PubMed ID: 2293100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors.
    Geyer MA; Tapson GS
    Neuropsychopharmacology; 1988 May; 1(2):135-47. PubMed ID: 3150805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin.
    Cassel JC; Jeltsch H; Neufang B; Lauth D; Szabo B; Jackisch R
    Brain Res; 1995 Dec; 704(2):153-66. PubMed ID: 8788910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the 5-HT2 receptor antagonist, ritanserin, on biogenic amines in the rat nucleus accumbens.
    Devaud LL; Hollingsworth EB
    Eur J Pharmacol; 1991 Jan; 192(3):427-9. PubMed ID: 1675992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the pharmacology of 9,10-dihydro-10-(1-methyl-4-piperidylidene)-9-anthrol (WA 335), a histamine and serotonin antagonist (author's transl)].
    Engelhardt G
    Arzneimittelforschung; 1975 Nov; 25(11):1723-37. PubMed ID: 1049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centrally active antimuscarinic analogs of oxotremorine selectively block physostigmine-induced hypertension, but not peripheral muscarinic vasodepression.
    Vargas HM; Ringdahl B
    J Pharmacol Exp Ther; 1990 Apr; 253(1):165-70. PubMed ID: 2329503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of serotoninergic receptor antagonists and their combination with scopolamine on memory.
    Petkov VD; Markovska VL; Petkov VV
    Acta Physiol Pharmacol Bulg; 1991; 17(1):21-8. PubMed ID: 1815467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of acute platelet thrombosis formation in stenosed canine coronary arteries by specific serotonin 5HT2 receptor antagonist ritanserin.
    Torr S; Noble MI; Folts JD
    Cardiovasc Res; 1990 Jun; 24(6):465-70. PubMed ID: 2117499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scopolamine self-administration: cholinergic involvement in reward mechanisms.
    Glick SD; Guido RA
    Life Sci; 1982 Aug; 31(9):909-13. PubMed ID: 7176819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-voltage electroencephalogram spindles in rats, aging and 5-HT2 antagonism.
    Moyanova S; Kortenska L; Kirov R
    Brain Res; 1998 Mar; 786(1-2):55-63. PubMed ID: 9554952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABA-B receptor activation and conflict behaviour.
    Ketelaars CE; Bollen EL; Rigter H; Bruinvels J
    Life Sci; 1988; 42(8):933-42. PubMed ID: 2893966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.